NCT06607939
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT06607939
Title ORB-021 in Patients with Advanced Solid Tumors (OR2-01)
Acronym OR2-01
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Orionis Biosciences Inc
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA


No variant requirements are available.